Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Sees Significant Increase in Short Interest

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 400 shares, an increase of 300.0% from the February 28th total of 100 shares. Based on an average daily volume of 3,200 shares, the short-interest ratio is presently 0.1 days.

Relief Therapeutics Price Performance

Shares of Relief Therapeutics stock traded down $0.32 during trading hours on Thursday, hitting $2.54. 1,587 shares of the company were exchanged, compared to its average volume of 2,545. The business has a 50-day moving average of $3.58 and a 200-day moving average of $4.46. Relief Therapeutics has a 1 year low of $1.10 and a 1 year high of $7.66.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.